This article illustrates multiple atypical manifestations of ocular toxoplasmosis masquerading as acute retinal necrosis and vitreoretinal lymphoma.
Methods:
Two case presentations are discussed, and the body of pertinent literature is reviewed and discussed.
Results:
In these cases, an extensive workup and attention to history lead to the correct diagnosis and management.
Conclusions:
Aggressive cases of ocular toxoplasmosis may present in a variety of phenotypes that may mimic other vision- and potentially life-threatening conditions, particularly in a milieu of inadequate endogenous and exogenous antimicrobial defenses.
HollandGN. Ocular toxoplasmosis: a global reassessment, part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136(6):973–988. doi:10.1016/j.ajo.2003.09.040
2.
Robert-GangneuxFDardéML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–296. doi:10.1128/CMR.05013-11
3.
JonesJLSehgalMMaguireJH. Toxoplasmosis-associated deaths among human immunodeficiency virus-infected persons in the United States, 1992-1998. Clin Infect Dis. 2002;34(8):1161. doi:10.1086/339752
4.
Bosch-DriessenLHBerendschotTJOngkosuwitoJVRothovaA. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109(5):869–878. doi:10.1016/s0161-6420(02)00990-9
5.
HenderlyDEGenstlerAJSmithRERaoNA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103(2):131–136. doi:10.1016/s0002-9394(14)74217-5
6.
AdamCRAbramsG. Toxoplasmosis retinochoroiditis masquerading as endogenous endophthalmitis in a case of congenital long QT syndrome. Retin Cases Brief Rep. Published online September 4, 2020. doi:10.1097/ICB.0000000000001048
MittraRAPulidoJSHansonGAKajdacsy-BallaABrummittCF. Primary ocular Epstein-Barr virus-associated non-Hodgkin’s lymphoma in a patient with AIDS. Retina. 1999;19(1):45–50. doi:10.1097/00006982-199901000-00007
10.
GreigertVDi FoggiaEFilisettiD, et al.When biology supports clinical diagnosis: a review of techniques to diagnose ocular toxoplasmosis. Br J Ophthalmol. 2019;103(7):1008–1012. doi:10.1136/bjophthalmol-2019-313884
11.
ErreraMHGoldschmidtPBatellierL, et al.Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2011;249(12):1837–1846. doi:10.1007/s00417-011-1724-7
12.
Robert-GangneuxFDardéML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–296. doi:10.1128/CMR.05013-11
13.
FekkarABodaghiBTouafekFLe HoangPMazierDParisL. Comparison of immunoblotting, calculation of Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2008;46(6):1965–1967. doi:10.1128/JCM.01900-07
14.
TalabaniHAsserafMYeraH, et al.Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J Clin Microbiol. 2009;47(7):2131–2135. doi:10.1128/JCM.00128-09
15.
KotreshaDNoordinR. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS. 2010;118(8):529–542. doi:10.1111/j.1600-0463.2010.02629.x
BaharivandNMahdavifardAFouladiRF. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial. Int Ophthalmol. 2012;33(1):39–46. doi:10.1007/s10792-012-9634-1
18.
SoheilianMRamezaniAAzimzadehA, et al.Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2010;118(1):134–141. doi:10.1016/j.ophtha.2010.04.020
19.
Fernández ZamoraYFArantesTReisFA, et al.Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone. Arq Bras Oftalmol. 2015;78(4):216–219. doi:10.5935/0004-2749.20150056
20.
LashayAMirshahiAParandinN, et al.A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis. J Curr Ophthalmol. 2017;29(2):120–125. doi:10.1016/j.joco.2016.10.002
21.
Bosch-DriessenLHVerbraakFDSuttorp-SchultenMSA, et al.A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002;134(1):34–40. doi:10.1016/s0002-9394(02)01537-4
22.
BalaskasKVaudauxJBoillat-BlancoNGuex-CrosierY. Azithromycin versus sulfadiazine and pyrimethamine for non-vision threatening toxoplasmic retinochoroiditis: a pilot study. Med Sci Monit. 2012;18(5):CR296–CR302. doi:10.12659/msm.882735
23.
PearsonPAPirachaARSenHAJaffeGJ. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology. 1999;106(1):148–153. doi:10.1016/S0161-6420(99)90021-0
24.
JasperSVedulaSSJohnSSHoroSSepahYJNguyenQD. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst Rev. 2017;1(1):CD007417. doi:10.1002/14651858.CD007417.pub3
25.
RushRShethS. Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration. Indian J Ophthalmol. 2012;60(2):141–143. doi:10.4103/0301-4738.94059
26.
SilveiraCBelfortRJrMuccioliC, et al.The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–46. doi:10.1016/s0002-9394(02)01527-1
27.
Fernandes FelixJPCavalcanti LiraRPGrupenmacherAT, et al.Long-term results of trimethoprim- sulfamethoxazole versus placebo to reduce the risk of recurrent Toxoplasma gondii retinochoroiditis. Am J Ophthalmol. 2020;213:195–202. doi:10.1016/j.ajo.2019.12.025
28.
AdánAGiralt J AlvarezG, et al.Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009;19(6):1039–1043.
